GRPH stock pitch - 2023-04-24

Added to YB: 2023-04-24

Pitch date: 2023-04-24

Graphite Bio, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc., in a reverse merger transaction.

Market Cap

$185.2M

Pitch Price

$13.91

Price Target

N/A

Dividend

N/A

EV/EBITDA

-0.02

P/E

-1.45

EV/Sales

N/A

Sector

Biotechnology

A summary for this pitch has not been created yet.